64 citations
Counting papers with at most 25 authors, so collaboration author lists do not stand in for the people here.
- Medical University of ViennaAT3 papers
- Berry Consultants, LLC (United States)US2 papers
- Lancaster UniversityGB2 papers
- Novartis (Switzerland)CH2 papers
- Paul Ehrlich InstitutDE2 papers
- Apple (United States)US1 paper
- AstraZeneca (Sweden)SE1 paper
- Bayer (United States)US1 paper
- Becton Dickinson (Canada)CA1 paper
- Berry (United States)US1 paper
- Biogen (United States)US1 paper
- Charité - Universitätsmedizin BerlinDE1 paper
3 papers · 1 filter
Treatment-control comparisons in platform trials including non-concurrent controls
Marta Bofill Roig, Pavla Krotka, Katharina Hees +5
Shared controls in platform trials comprise concurrent and non-concurrent controls. For a given experimental arm, non-concurrent controls refer to data from patients allocated to t…
On model-based time trend adjustments in platform trials with non-concurrent controls
Marta Bofill Roig, Pavla Krotka, Carl-Fredrik Burman +9
Platform trials can evaluate the efficacy of several treatments compared to a control. The number of treatments is not fixed, as arms may be added or removed as the trial progresse…
Propensity Score Weighting for Causal Subgroup Analysis
Siyun Yang, Elizabeth Lorenzi, Georgia Papadogeorgou +3
A common goal in comparative effectiveness research is to estimate treatment effects on pre-specified subpopulations of patients. Though widely used in medical research, causal inf…